With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
Over the past two years, we have successfully established the user research practice at BenevolentAI covering user research operations, training and upskilling initiatives, and evaluation programmes. As a Senior User Researcher, you will lead the evolution of this practice by taking the responsibility for shaping it and influencing how user research is done across the company. In this role, you will be involved in all aspects of product development, from early-stage concept generation and usability evaluation, to informing product strategy at large and measuring the impact our products have on drug discovery. You will work closely with drug discovery scientists — our internal users — and with members of our cross-functional product development teams who will rely on your insight and support to understand and analyse user motivations, needs, and behaviours. You will uncover and help us understand non-trivial user needs focused around exploring and understanding vast quantities of mined and inferred biomedical data, and using it to make scientific and business decisions.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email email@example.com. Thank you.